Sanofi India share price has zoomed 4% and is presently trading at Rs 7,074.8.
Meanwhile, the BSE HEALTHCARE index is at 43,320.5 (up 0.8%).
Among the top gainers in the BSE HEALTHCARE index today are POLY MEDICURE (up 6.0%) and GLAND PHARMA (up 4.3%).
SUN PHARMA ADV. RES. (down 1.0%) and HIKAL CHEMIC (down 0.5%) are among the top losers today.
Over the last one year, Sanofi India has moved down from Rs 7,139.2 to Rs 7,074.8, registering a loss of Rs 64.4 (down 0.9%).
On the other hand, the BSE HEALTHCARE index has moved up from 27,871.2 to 43,320.5, registering a gain of 55.4% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were GRANULES INDIA (up 129.3%), Glenmark Pharma (up 125.8%) and SUVEN PHARMACEUTICALS (up 115.2%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 82,474.1 (down 0.1%).
The top losers among the BSE Sensex today are Bajaj Finance (down 1.9%) and Bajaj Finserv (down 1.0%). The most traded stocks in the BSE Sensex are Tata Steel and ITC.
In the meantime, NSE Nifty is at 25,256.7 (down 0.1%). Bajaj Finance and IOC are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 65,087.3 to 82,474.1, registering a gain of 17,386.8 points (up 26.7%).
Sanofi India net profit fell 15.8% YoY to Rs 682 million for the quarter ended June 2024, compared to a profit of Rs 810 million a year ago. Net sales declined 10.0% to Rs 4,635 million during the period as against Rs 5,149 million in April-June 2023.
For the year ended December 2023, Sanofi India reported 2.9% decrease in net profit to Rs 6,029 million compared to net profit of Rs 6,206 million during FY22. Revenue of the company grew 2.9% to Rs 28,511 million during FY23.
The current Price to earnings ratio of Sanofi India, based on rolling 12 month earnings, stands at 33.0.
Equitymaster requests your view! Post a comment on "Sanofi India Gains 4%; BSE HEALTHCARE Index Up 0.8%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!